Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Biologic Endpoints in the Annihilation of Metastases for Oligometastasis (BEAM ON)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01706432
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:20.203255+00:00
Published At
2024-07-31T00:00:00+00:00
Record Updated At
2024-07-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Central Nervous System Metastases", "Invasive Ductal Breast Carcinoma", "Invasive Ductal Breast Carcinoma With Predominant Intraductal Component", "Invasive Lobular Breast Carcinoma", "Invasive Lobular Breast Carcinoma With Predominant in Situ Component", "Liver Metastases", "Lobular Breast Carcinoma in Situ", "Lung Metastases", "Male Breast Cancer", "Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate", "Mucinous Ductal Breast Carcinoma", "Papillary Ductal Breast Carcinoma", "Recurrent Breast Cancer", "Stage IV Breast Cancer", "Tubular Ductal Breast Carcinoma", "Tumors Metastatic to Brain"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-07-31"
protocolSection.identificationModule.nctId
"NCT01706432"
protocolSection.identificationModule.officialTitle
"Biologic Endpoints in the Annihilation of Metastases for Oligometastasis (BEAM ON)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Central Nervous System Metastases (protocolSection.conditionsModule.conditions)
  • Invasive Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Invasive Ductal Breast Carcinoma With Predominant Intraductal Component (protocolSection.conditionsModule.conditions)
  • Invasive Lobular Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Invasive Lobular Breast Carcinoma With Predominant in Situ Component (protocolSection.conditionsModule.conditions)
  • Liver Metastases (protocolSection.conditionsModule.conditions)
  • Lobular Breast Carcinoma in Situ (protocolSection.conditionsModule.conditions)
  • Lung Metastases (protocolSection.conditionsModule.conditions)
  • Male Breast Cancer (protocolSection.conditionsModule.conditions)
  • Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate (protocolSection.conditionsModule.conditions)
  • Mucinous Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Papillary Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Breast Cancer (protocolSection.conditionsModule.conditions)
  • Tubular Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Tumors Metastatic to Brain (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.